CINECA IRIS Institutional Research Information System

LATROFA, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.592
NA - Nord America 8.422
AS - Asia 992
AF - Africa 183
SA - Sud America 47
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 20.246
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.328
US - Stati Uniti d'America 5.963
CA - Canada 2.447
SE - Svezia 688
CN - Cina 436
DE - Germania 325
BG - Bulgaria 266
SG - Singapore 236
GB - Regno Unito 189
AT - Austria 164
FR - Francia 154
UA - Ucraina 132
VN - Vietnam 104
CI - Costa d'Avorio 92
TR - Turchia 85
FI - Finlandia 79
SN - Senegal 57
CH - Svizzera 53
IN - India 49
RU - Federazione Russa 30
BE - Belgio 26
HK - Hong Kong 26
ES - Italia 22
NL - Olanda 21
PL - Polonia 20
RO - Romania 19
IE - Irlanda 15
BR - Brasile 14
GR - Grecia 13
JP - Giappone 13
MX - Messico 11
ZM - Zambia 11
PY - Paraguay 10
ZA - Sudafrica 9
CZ - Repubblica Ceca 8
JO - Giordania 8
CO - Colombia 7
AU - Australia 6
DK - Danimarca 6
IR - Iran 6
KR - Corea 6
SM - San Marino 6
TH - Thailandia 6
EG - Egitto 5
HR - Croazia 5
HU - Ungheria 5
CL - Cile 4
EC - Ecuador 4
KZ - Kazakistan 4
MT - Malta 4
PE - Perù 4
AL - Albania 3
AR - Argentina 3
LY - Libia 3
PK - Pakistan 3
RS - Serbia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
EU - Europa 2
IL - Israele 2
IQ - Iraq 2
NG - Nigeria 2
PT - Portogallo 2
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
IS - Islanda 1
KE - Kenya 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
ME - Montenegro 1
MY - Malesia 1
PH - Filippine 1
PR - Porto Rico 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 20.246
Salva come PNG Salva come JPEG
Città #
Montreal 2.316
Fairfield 767
Woodbridge 746
Milan 726
Ann Arbor 582
Houston 493
Rome 450
Chandler 442
Ashburn 325
Seattle 321
Sofia 262
Wilmington 254
Cambridge 239
Beijing 207
Serra 206
Florence 205
New York 197
Naples 180
Vienna 148
Singapore 128
Boardman 127
Princeton 121
Ottawa 118
Pisa 107
Lawrence 106
Medford 95
Bologna 94
Abidjan 92
Turin 85
Bari 81
Palermo 80
Catania 67
Nanjing 67
Brescia 66
Izmir 65
Des Moines 61
London 58
Dakar 57
Dong Ket 56
Bremen 53
Vicopisano 53
Padova 48
Genoa 47
Livorno 46
Dearborn 44
San Diego 42
Jacksonville 37
Redwood City 36
Verona 35
Dallas 32
Marseille 31
Ogden 31
Cagliari 30
Lancaster 29
Lucca 28
Bergamo 27
Napoli 27
Boulder 26
Nanchang 26
Modena 24
Perugia 24
Frankfurt am Main 22
Hong Kong 22
Salerno 21
Torino 20
Brussels 18
Kunming 18
Los Angeles 18
Helsinki 17
Messina 17
Pescara 17
Rende 17
Cosenza 16
Monza 16
Munich 16
Reggio Calabria 16
Taranto 16
Venice 16
Ancona 15
Caserta 15
Giugliano in Campania 15
Novara 15
Santa Clara 15
Cinisello Balsamo 14
Lecce 14
Reggio Emilia 14
Trieste 14
Norwalk 13
Vanzago 13
Bern 12
Hefei 12
Pontedera 12
Changsha 11
Chicago 11
Falls Church 11
Parma 11
San Francisco 11
Treviso 11
Andover 10
Carini 10
Totale 12.155
Salva come PNG Salva come JPEG
Nome #
Tiroidite cronica autoimmune 8.010
Ipotiroidismo subclinico 2.366
Gozzo diffuso tossico (morbo di Flajani-Basedow-Graves) e tiroidite cronica autoimmune, Inquadramento nosologico e terapia medica 159
Causes and laboratory investigations of thyrotoxicosis 155
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 151
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 149
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 147
Le malattie autoimmuni della tiroide 146
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 141
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation 137
Serum antibodies against megalin (gp330) in patients with autoimmune thyroiditis 134
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. 133
Pathogenetic and clinical aspects of autoimmune thyroiditis 131
Significance of low levels of thyroglobulin autoantibodies associated with undetectable thyroglobulin after thyroidectomy for differentiated thyroid carcinoma 130
The presence of anti-thyroglobulin (TgAb) and/or anti-thyroperoxidase antibodies (TPOAb) does not exclude the diagnosis of type 2 amiodarone-induced thyrotoxicosis 127
Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin. 126
Circulating thyroglobulin transcytosed by thyroid cells is complexed with secretory components of its endocytic receptor megalin 124
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 122
null 121
Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. 118
Effects of selenium on short-term control of hyperthyroidism due to Graves' disease treated with methimazole: results of a randomized clinical trial 117
Optic neuropathy in 2 thyroidectomized patients with moderate to severe Graves’ ophthalmopathy following L-thyroxine withdrawal prior to radioiodine treatment for thyroid carcinoma 116
The large majority of 1520 patients with indeterminate thyroid nodule at cytology have a favorable outcome, and a clinical risk score has a high negative predictive value for a more cumbersome cancer disease. 115
Outcome of Graves’ Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial 114
Clinical features of thyroid autoimmunity are associated with thyroiditis on histology and are not predictive of malignancy in 570 patients with indeterminate nodules on cytology who had a thyroidectomy 113
Disappearance of Anti-Thyroid Autoantibodies following Thymectomy in Patients with Myasthenia Gravis 112
Intracellular retention of thyroglobulin in the absence of the low-density lipoprotein receptor-associated protein (RAP) is likely due to premature binding to megalin in the biosynthetic pathway 111
VARIABLES AFFECTING THE LONG TERM OUTCOME OF GRAVES' ORBITOPATHY FOLLOWING HIGH DOSE INTRAVENOUS GLUCOCORTICOID PULSE THERAPY IN PATIENTS NOT TREATED WITH ORBITAL RADIOTHERAPY 111
Fifty years after the first description, the MEN 2B syndrome diagnosisis still late: description of two recent cases 111
Effects Of Long-term Tamoxifen Therapy On The Course Of Chronic Autoimmune Thyroiditis 110
Outcome of Graves' Orbitopathy after Total Thyroid Ablation and Glucocorticoid Treatment: Follow-Up of a Randomized Clinical Trial 108
Thyroid volume and severity of graves' orbitopathy 108
Association of T and B Cells Infiltrating Orbital Tissues With Clinical Features of Graves Orbitopathy 108
Patients with indeterminate thyroid nodules at cytology and cancer at histology have a more favourable outcome with respect to patients with suspicious or malignant cytology 106
Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine 105
Human monoclonal thyroglobulin autoantibodies: epitopes and immunoglobulin genes. 105
The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy 103
Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin. 102
Rehabilitative orbital decompression for Graves' orbitopathy: risk factors influencing the new onset of diplopia in primary gaze, outcome, and patients' satisfaction 101
null 100
null 100
Effect of thyroglobulin autoantibodies on the metabolic clearance of serum thyroglobulin 100
Enalapril reduces proliferation and hyaluronic acid release in orbital fibroblasts 99
Does Graves' Orbitopathy Ever Disappear? Answers to an Old Question 99
The BRAF-inhibitor PLX4720 inhibits CXCL8 secretion in BRAFV600E mutated and normal thyroid cells: a further anti-cancer effect of BRAF-inhibitors 98
null 98
null 97
null 97
Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves' disease 96
null 93
null 91
null 91
Identification of thyroglobulin in orbital tissues of patients with thyroid-associated ophthalmopathy 91
Compared with classic Hashimoto’s thyroiditis, chronic autoimmune serum‑negative thyroiditis requires a lower substitution dose of l‑thyroxine to correct hypothyroidism 91
IgM thyroglobulin autoantibodies are detectable in serum of patients with subacute thyroiditis 90
Diagnosi differenziale dell’oftalmopatia basedowiana 89
Thyroglobulin changes are highly dependent on TSH in low-risk DTC patients not treated with 131I 89
null 88
Thyroglobulin Autoantibodies arise before Thyroperoxidase Autoantibodies in Juvenile Autoimmune Thyroiditis 88
null 87
null 86
The thyrotropin receptor autoantigen in Graves disease is the culprit as well as the victim. 86
Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy 86
Iodine, thyroid autoimmunity and cancer 83
Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N terminus of the thyrotropin receptor A-subunit. 82
Diagnosi di laboratorio 82
Graves' Disease Induced by Immune Checkpoint Inhibitors: A case report and Review of the literature 82
Evidence that the thyrotropin receptor protease is membrane-associated and is not within lipid rafts 80
Influence of Lymphocytic Thyroiditis at Histology and Serum Thyroglobulin Autoantibodies on the Course of Papillary Thyroid Carcinoma 79
Patients with Indeterminate Thyroid Nodules at Cytology and Cancer at Histology Have a More Favorable Outcome Compared with Patients with Suspicious or Malignant Cytology 78
Orbital diseases mimicking graves’ orbitopathy: a long-standing challenge in differential diagnosis 78
The detection of serum IgM to thyroglobulin in subacute thyroiditis suggests a protective role of IgM in thyroid autoimmunity 77
null 76
Thyroglobulin Autoantibodies Switch to IgG1 and IgG3 Subclasses after 131I Treatment for Graves' Hyperthyroidism: Autoantibodies Subclasses Are Related to the Activity of Autoimmune Thyroid Disease 75
Effect of thyroglobulin autoantibodies on the clearance of serum thyroglobulin in humans 75
Intravenous glucocorticoid therapy for Graves' ophthalmopathy and acute liver damage: an epidemiological study 74
Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves’ Disease: results of a pilot study 73
Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor. 72
Thyroglobulin-thyroperoxidase autoantibodies are polyreactive, not bispecific: analysis using human monoclonal autoantibodies. 72
Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player? 71
Subacute thyroiditis after Sars-COV-2 infection 71
null 70
Hypothyroidism Due to L-T4 Withdrawal Can Precipitate Optic Neuropathy in Patients with Moderate to Severe Graves' Ophthalmopathy: Report on Two Cases 70
Evaluation of the Level of Thyroglobulin Autoantibodies Interfering with Thyroglobulin Measurement in Patients with Differentiated Thyroid Carcinoma 70
Diffuse and Nodular Goiter 69
Un caso di MEN2B con anomalie scheletriche multiple 68
Manifestaciones no oftalmológicas de la enfermedad de Graves 67
null 67
Is subacute thyroiditis an underestimated manifestation of SARS-CoV-2 infection? insights from a case series 66
null 65
null 65
The detection of serum IgMs to thyroglobulin in subacute thyroiditis suggests a protective role of IgMs in thyroid autoimmunity 64
Clinical heterogeneity of hypophysitis secondary to PD-1/PD-L1 blockade: insights from four cases 61
Management of thyrotoxicosis induced by PD1 or PD-L1 blockade 61
null 59
Gozzo 58
Activating Antibodies to the Calcium-sensing Receptor in Immunotherapy-induced Hypoparathyroidism 57
Thyroid imaging in the management of anti-PD1/PD-L1 induced thyrotoxicosis 56
Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis 56
Thyroid autoimmunity, thyroglobulin autoantibodies and thyroid cancer prognosis 53
Totale 19.715
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.808
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.808
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.835 0 0 0 184 218 251 258 199 200 179 232 114
2020/20211.654 158 113 146 116 155 96 97 148 148 137 133 207
2021/20221.926 61 103 61 152 297 239 83 97 194 154 108 377
2022/20233.354 250 306 246 219 250 269 146 261 506 192 425 284
2023/20246.559 364 317 315 311 383 462 377 354 204 2.651 405 416
2024/20251.255 390 347 370 148 0 0 0 0 0 0 0 0
Totale 20.568